MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0010901
Unitas Pharmaceuticals Private Limited
Unitas Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.02 Cr
▲ 78% YoY
Net profit · FY 2025
₹62.66 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹94.29 Lakh
EBITDA margin 3.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹73.64 Lakh
Issued & subscribed
Open charges
₹2.98 Cr
Satisfied ₹2.25 Cr
Company age
32 yrs
Est. 1994
Directors on board
2
As per MCA filings
About Unitas Pharmaceuticals Private Limited
Data last updated:
Unitas Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC057671. Its GSTIN is 07AAACU1246K1ZD (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹73.64 Lakh. It is led by directors Neelam Nijhawan and Akhilesh Chander Nagar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at R – 28 Inderpuri, New Delhi, Delhi, India – 110012.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.02 Cr, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹62.66 Lakh (net margin 2.6%) and EBITDA of ₹94.29 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 17% over five years.
As per MCA filings, the company has open charges of ₹2.98 Cr and satisfied charges of ₹2.25 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 1 case is pending.
Unitas Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0010901). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1994PTC057671
Registration Number 057671
Incorporation Date 02 March 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0010901
Recognitions & Rankings of Unitas Pharmaceuticals
Contact details
Unitas Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR – 28 Inderpuri, New Delhi, Delhi, India – 110012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unitas Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Unitas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unitas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unitas Pharmaceuticals Private Limited, buy the company report.
Financials of Unitas Pharmaceuticals Private Limited
FY 2024 filings availableUnitas Pharmaceuticals Private Limited reported revenue of ₹24.02 Cr (up 78% YoY) for FY 2025.
Revenue · FY 2025
₹24.02 Cr ▲ 78%
Net profit · FY 2025
₹62.66 Lakh margin 2.6%
EBITDA · FY 2025
₹94.29 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 16%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 4%
5 years · compounded
▲ 10%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 78% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unitas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unitas Pharmaceuticals Private Limited
Unitas Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Nijhawan | Director | 14 Jan 2001 | 25 Years 9 Months | Current |
| Akhilesh Chander Nagar Also directs: Unitas Life Sciences Private Limited | Director | 02 Mar 1994 | 32 Years 7 Months | Current |
Peer comparison
Unitas Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Namanidhi Pharmaceutical Private Limited | ₹24.15 Cr (FY 2024) | 31.0% | Ahmedabad, Gujarat, India | |||
| Friends Medicos Private Limited | ₹24.04 Cr (FY 2025) | 22.0% | Delhi, India | |||
| Unitas Pharmaceuticals Private Limitedthis company | ₹24.02 Cr (FY 2025) | ₹62.66 Lakh | 2.6% | 78.0% | New Delhi, Delhi, India | |
| Southern Surgicals Private Limited | ₹23.98 Cr (FY 2025) | 10.0% | Bangalore, Karnataka, India | |||
| MG Worldwide Private Limited | ₹23.94 Cr (FY 2025) | 35.0% | New Delhi, Delhi, India | |||
| Yolo Eximcare Private Limited | ₹23.93 Cr (FY 2025) | 98.0% | P S Kotwali, Bihar, India |
To see the full peer comparison of Unitas Pharmaceuticals Private Limited, buy the company report.
Auditor
Unitas Pharmaceuticals Private Limited is audited by VINEET OJHA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINEET OJHA & CO. | FY 2023 | 005831N |
Shareholding
The shareholding of Unitas Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unitas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.98 Cr
Satisfied charges
₹2.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 May 2023 | 100755689 | Hdfc Bank Limited | ₹24.34 Lakh | Open | |
| 30 Jul 2013 | 10450560 | Others | ₹2.74 Cr | Open | |
| 02 Apr 2003 | 90058088 | State Bank of India | ₹2.15 Cr | Satisfied | |
| 28 Sep 1999 | 90057101 | Bank of India | ₹2.46 Lakh | Satisfied | |
| 28 Sep 1999 | 90057113 | Bank of India | ₹7.5 Lakh | Satisfied |
To see the full charge records of Unitas Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Unitas Pharmaceuticals Private Limited has 6 court cases on record: 6 filed against it. 1 case is pending and 5 are disposed.
Total cases
6
Filed against the company
6
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed against the company by Ms Wings Pharmaceuticals (P) Ltd | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
To see the full case history of Unitas Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unitas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unitas Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACU1246K1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unitas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unitas Pharmaceuticals Private Limited has 2 board changes on record since 1994: 2 appointments. The latest: Neelam Nijhawan was appointed as Director on 14 Jan 2001.
Charges
A charge registered on 02 Apr 2003 via Charge ID 90058088 with State Bank Of India was fully satisfied on 30 May 2025.
AGM
Unitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Unitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.24 Cr with Charge ID 100755689 was registered on 24 May 2023.
Charges
A charge with Others of Rs. 2.74 Cr registered on 30 Jul 2013 with Charge ID 10450560 was modified on 07 Aug 2020.
Charges
A charge with Others amounted to Rs. 2.74 Cr with Charge ID 10450560 was registered on 30 Jul 2013.
Charges
A charge with State Bank Of India of Rs. 2.15 Cr registered on 02 Apr 2003 with Charge ID 90058088 was modified on 26 Mar 2011.
Charges
A charge registered on 28 Sep 1999 via Charge ID 90057101 with Bank Of India was fully satisfied on 22 Oct 2004.
Charges
A charge registered on 28 Sep 1999 via Charge ID 90057113 with Bank Of India was fully satisfied on 22 Oct 2004.
Charges
A charge with State Bank Of India amounted to Rs. 2.15 Cr with Charge ID 90058088 was registered on 02 Apr 2003.
Appointed
Neelam Nijhawan was appointed as Director.
Charges
A charge with Bank Of India of Rs. 0.08 Cr registered on 28 Sep 1999 with Charge ID 90057113 was modified on 20 Jul 2000.
4 earlier events are in the company report.
Frequently asked questions
Unitas Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 1994 (32+ years old) and is registered under CIN U74899DL1994PTC057671.
Unitas Pharmaceuticals has 2 current directors:
- Neelam Nijhawan - Director
- Akhilesh Chander Nagar - Director
The latest financial statements of Unitas Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Unitas Pharmaceuticals is 07AAACU1246K1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Unitas Pharmaceuticals is U74899DL1994PTC057671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unitas Pharmaceuticals has 6 court cases on record: 6 filed against it. 1 is pending.
Unitas Pharmaceuticals was incorporated on 02 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Unitas Pharmaceuticals by revenue are Namanidhi Pharmaceutical Private Limited, Friends Medicos Private Limited, Southern Surgicals Private Limited, MG Worldwide Private Limited, Yolo Eximcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Neelam Nijhawan was appointed as Director on 14 Jan 2001. Akhilesh Chander Nagar was appointed as Director on 02 Mar 1994.
Yes, Unitas Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0010901).
The registered office of Unitas Pharmaceuticals is at R – 28 Inderpuri, New Delhi, Delhi, India – 110012.